Anixa Biosciences, Inc. (ANIX)
Last updated: 2026-10-21 06:13:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Summary
Anixa Biosciences, Inc. (ANIX) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $2.68, with a market capitalization of $92.82M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2.32 to $5.46. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$92.82M | |
$2.64 | |
$8.09 | |
$1.33 | |
$2.61 | |
144.60K | |
290.39K | |
-- | |
$5.46 | |
$2.32 | |
-- | |
-- |
Anixa Biosciences, Inc. (ANIX) Latest Closing Stock Price
Anixa Biosciences, Inc. (ANIX) last closed at $2.61 as of 2026-10-20 23:38:00, unchanged from the previous close of $2.61.
During the latest regular trading session, ANIX traded between $1.33 and $8.09, with a volume of 144.60K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Anixa Biosciences, Inc. (ANIX) 7-Day Stock Price Change
Over the past seven days, Anixa Biosciences, Inc. (ANIX) moved from $2.90 to $2.68, representing a decline of 7.55% ($0.22).
The stock traded between $2.60 and $2.96 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 165.43 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
ANIX 52-Week Price Position
Position in Range: 11.5%
ANIX is currently trading at $2.68, placing it 11.5% of the way from its 52-week low of $2.32 to its 52-week high of $5.46. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Anixa Biosciences, Inc. (ANIX)?
Anixa Biosciences Inc is a biotechnology company developing therapies and vaccines focused on critical unmet needs in oncology. Its operations are organized into reportable segments comprising Cancer Vaccines, CAR-T Therapies, and Other. The Cancer Vaccines segment involves vaccines to treat and prevent breast and ovarian cancer, as well as additional cancer vaccines targeting intractable cancers, including high-incidence malignancies in lung, colon, and prostate. The CAR-T Therapies segment involves the development of liraltagene autoleucel (lira-cel), an ovarian cancer immunotherapy using chimeric endocrine receptor-T cell technology, developed at its subsidiary, Certainty Therapeutics, Inc. The Other segment consists of legacy operations, including limited patent licensing activities.
Anixa Biosciences, Inc. Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 4 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Anixa Biosciences, Inc. (ANIX) Stock on MEXC
Eligible investors can buy real shares of Anixa Biosciences, Inc. (ANIX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Anixa Biosciences, Inc. (ANIX) stock price today?
2.Is ANIX stock going up or down today?
3.What is ANIX pre-market price?
4.What is ANIX after-hours price?
5.Is ANIX stock trading now?
6.Where does ANIX sit relative to its 52-week high and low?
7.What sector is Anixa Biosciences, Inc. in?
8.What is Anixa Biosciences, Inc.'s market capitalization and where is it listed?
9.How is ANIX valued in terms of P/E ratio and EPS?
10.Does Anixa Biosciences, Inc. pay a dividend?
Explore More US Stocks
Search Stocks
ANIX Stock Calculator
Estimate the value between ANIX shares and USD.
ANIX Shares to USD
1.00 ANIX shares = 2.681 USD
Calculations are estimates based on the latest available price and are for reference only.


